Sterile pharmaceutical manufacturing demands uncompromising precision, stringent quality systems, and robust regulatory compliance.
Akums Drugs & Pharmaceuticals Ltd. — Unit III
Facility Type: Sterile Preparations Manufacturing Facility
Address: Plot No. 2, 3, 4 & 5, Sector-6B, IIE, SIDCUL, Ranipur,
Haridwar – 249403, Uttarakhand, India
Akums Plant 3 has been specifically designed to manufacture sterile pharmaceutical products under highly controlled environmental conditions. The facility integrates advanced cleanroom technologies, validated manufacturing systems, automated process controls, and comprehensive quality assurance practices to ensure sterility, product integrity, and regulatory compliance throughout the manufacturing lifecycle.
Every manufacturing operation is executed in accordance with current Good Manufacturing Practices (cGMP), supported by robust quality systems, environmental monitoring programs, and validated aseptic processing techniques that minimize contamination risks while ensuring consistent product quality.
At Akums Plant 3, we combine advanced manufacturing technologies, validated aseptic processes, and decades of pharmaceutical expertise to deliver sterile dosage forms that meet the highest international quality standards.
Located in Haridwar's pharmaceutical manufacturing hub, the facility serves both domestic and international markets with world-class infrastructure, highly trained professionals, and globally accepted quality systems that ensure consistency from development to commercial production.
Dedicated Manufacturing Units
9001, 14001, 45001 & 50001 Certified
Global Regulatory Approvals
Compliant Manufacturing
Akums Plant 3 is equipped to manufacture a broad portfolio of sterile pharmaceutical products, giving customers access to multiple manufacturing capabilities under one integrated facility.
Dedicated to high-quality sterile injectable formulations across diverse packaging formats, employing validated aseptic filling systems, advanced sterilization technologies, and stringent environmental controls.
Dedicated containment systems and segregated manufacturing areas for cephalosporin antibiotics, ensuring complete product segregation and contamination control.
Exclusively designed for penicillin-based sterile products with complete segregation from other manufacturing areas.
Supports production of sterile eye drops and nasal drops, manufactured under aseptic conditions with stringent environmental monitoring.
Additional sterile dry powder injectable manufacturing, providing scalable manufacturing capacity for diverse therapeutic applications.
Critical sterile utility systems supporting aseptic production and injectable manufacturing across every unit.
Quality is not limited to final product testing — it is integrated into every stage of manufacturing. From raw material qualification to final product release, every manufacturing activity follows validated Standard Operating Procedures supported by scientific risk management and continuous quality oversight.
Manufacturing processes are developed and continuously optimized to ensure consistent product quality and process robustness.
Validated aseptic processing, environmental monitoring, personnel qualification, and sterilization validation collectively ensure sterility throughout production.
Electronic systems, validated documentation practices, and audit-ready processes ensure complete traceability across every manufacturing stage.
Manufacturing processes are routinely reviewed to identify opportunities for efficiency enhancement, quality improvement, and operational excellence.
Sterile pharmaceutical manufacturing requires far more than advanced equipment — it demands precision, process discipline, regulatory rigor, and an unwavering commitment to quality. Our integrated approach combines advanced manufacturing infrastructure, qualified technical expertise, validated processes, and robust quality systems to ensure reliable production across diverse sterile dosage forms.
Our management systems demonstrate our commitment to quality, environmental responsibility, workplace safety, and sustainable manufacturing practices. These approvals reinforce our capability to manufacture pharmaceutical products for regulated, semi-regulated, and emerging international markets.
Quality Management System, certified by QMS Certification Services Pvt. Ltd.
Environmental Management System, certified by QMS Certification Services Pvt. Ltd.
Occupational Health & Safety Management System, certified by RIR Certification Pvt. Ltd.
Energy Management System, certified by BSI Certification.
European Union Good Manufacturing Practice approval.
Akums Plant 3 holds approvals from multiple international regulatory authorities, reflecting the facility's adherence to globally accepted pharmaceutical manufacturing standards.
Brazil
Uttarakhand, India
Bulgaria
Cambodia
Ethiopia
Malawi
Nepal
Nigeria
Philippines
Sudan
Uganda
Every sterile product manufactured at Akums Plant 3 ultimately reaches patients who rely on consistent quality and uncompromised safety. This responsibility drives every manufacturing decision we make. From infrastructure design and process validation to quality assurance and regulatory compliance, our teams work together to ensure that every batch leaving our facility meets the highest standards of sterility, safety, efficacy, and quality.
Akums Plant 3 represents the convergence of advanced sterile manufacturing, scientific expertise, global quality systems, and scalable pharmaceutical production. Whether you are developing innovative therapies, expanding commercial manufacturing, or seeking a reliable CDMO partner, our facility offers the infrastructure, technical expertise, and regulatory excellence needed to accelerate your product journey. Connect with Akums to explore world-class sterile manufacturing solutions tailored to your business needs.
Plant 3 is located at Plot No. 2, 3, 4 & 5, Sector-6B, IIE, SIDCUL, Ranipur, Haridwar – 249403, Uttarakhand, India, within Haridwar's pharmaceutical manufacturing hub.
Plant 3 manufactures ampoules, vials, three-piece systems, LVP, SVP, prefilled syringes, dry powder injectables (including cephalosporins and penicillin), and sterile ophthalmic and nasal preparations.
Cephalosporin and penicillin manufacturing are handled in fully segregated, dedicated units with specialized HVAC systems, controlled personnel movement, and validated cleaning protocols to prevent cross-contamination.
The facility holds ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, and ISO 50001:2018 certifications, along with EU GMP and multiple international regulatory approvals.
Plant 3 holds approvals from authorities including ANVISA Brazil, the Bulgarian Drug Agency, NAFDAC Nigeria, the Philippines FDA, and health ministries across Cambodia, Ethiopia, Malawi, Nepal, Sudan, and Uganda, supporting regulated, semi-regulated, and emerging markets.
Yes. The facility offers scalable production capabilities across all five units, supported by validated utilities, robust quality systems, and continuous process improvement practices.
Sterility assurance is supported by validated aseptic processing, environmental monitoring, personnel qualification, sterilization validation, and electronic data integrity systems.
Partner with Akums to elevate your pharmaceutical, nutraceutical, and cosmetic supply chain. As India's leading CDMO, we offer end-to-end solutions, including R&D, formulation development, and large-scale manufacturing. Our state-of-the-art facilities comply with stringent global standards, ensuring product safety, efficacy, and quality. With a strong focus on innovation, we deliver tailored solutions to meet your unique business needs. Whether you're launching a new product or enhancing your current supply chain, Akums provides reliable expertise, seamless scalability, and unwavering commitment to excellence. Join hands with Akums to strengthen your brand and achieve sustained growth in competitive markets.